| Thursday, May 30, 2013 |
|
12:30 PM — 1:00 PM
|
Box Lunch Provided
|
|
1:00 PM — 2:35 PM
|
Model Based Methods
- Introduction
Susan Halabi, PhD - Duke University Medical Center
- Case Presentation
William K. Kelly, DO - Thomas Jefferson University
- Traditional Phase I Designs
Gina Petroni, PhD - University of Virginia
- Model-Based Phase I Designs
Xiabou Ye, MD, MS - Sidney Kimmel Comprehensive Cancer Center
|
|
2:35 PM — 2:45 PM
|
Break
|
|
2:45 PM — 5:00 PM
|
Partial Order and Adaptive Bayesian Methods
- Partial and Group Order Phase I Designs
Mark Conaway - University of Virginia School of Medicine
- Practical Adaptive Bayesian Methods for Early Phase Clinical Trials
Peter Thall, PhD - The University of Texas MD Anderson Cancer Center
|
| Friday, May 31, 2013 |
|
7:00 AM — 7:30 AM
|
Continental Breakfast Provided
|
|
7:30 AM — 11:00 AM
|
Regulatory Perspective
- Biomarkers in Early Drug Development
Sue-Jane Wang - U.S. Food and Drug Administration
- Innovative Designs: FDA Perspective
Rajeshwari Sridhara, PhD - U. S. Food and Drug Administration
- Case Presentation
William K. Kelly, DO - Thomas Jefferson University
- Panel Discussion on Phase I Trials
|